Skip to content

Screening for chronic obstructive pulmonary disease (COPD) in patients hospitalized with chronic complex diseases. Utility of FEV1/FEV6 index for the diagnosis of chronic obstructive pulmonary disease, and prognostic implications

Screening for COPD in patients hospitalized with chronic complex diseases. Utility of FEV1/FEV6 index for the diagnosis of chronic obstructive pulmonary disease, and prognostic implications.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN10703543
Enrollment
200
Registered
2019-05-28
Start date
2017-09-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease in patients with multimorbidity Respiratory

Interventions

On the last day of hospitalization patients or their caregivers completed a questionnaire that included medical and socioeconomic variables, smoking history, prior diagnosis of chronical respiratory d

Sponsors

Mutua Terrassa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients hospitalized for any cause in the complex chronic patient care unit at University Hospital Mutua de Terrassa with = 2 chronic diseases according to the functional definition of polypathological patient of the Andalusia Health Department.

Exclusion criteria

Exclusion criteria: 1. No written informed consent to participation in the study. 2. Death during hospitalization. 3. Other reasons, apart from cognitive or functional impairment, which prevent the realization of FEV1/FEV6 (e.g., tracheotomy, facial paralysis….)

Design outcomes

Primary

MeasureTime frame
Prevalence and underdiagnosis of obstructive pulmonary disease, as measured by FEV1 / FEV6 and confirmed by subsequent spirometry in patients hospitalized in the complex chronic patient care unit. Measurement of the functional parameters, FEV1, FEV6, and FEV1/FEV6 ratio, was performed the last day of hospitalization, using the portable COPD-6 device (model 4000, Vitalograph Ltd., Ennis, Co. Clare, Ireland) and a portable spirometer. (Datoespir micro, Sibelmed, Barcelona Spain).

Secondary

MeasureTime frame
Variables are associated with the inability to successfully perform valid maneuvers to determine the FEV1/FEV6. 1. A questionnaire that included medical and socioeconomic variables, smoking history, prior diagnosis of chronical respiratory disease, results of the most recent spirometry if available, and domiciliary treatment. 2. Multimorbidity assessment was evaluated using the multimorbidity classification of the Andalusia Health Department, the Charlson index and a scale for other comorbid conditions not included in the Charlson index. 3.Physical functional status was assessed with the Barthel index. 4. Cognitive status was measured using the Pfeiffer test and the Mini-Mental Cognitive Examination in the Spanish version of Lobo et al. All measures were completed on the last day of hospitalisation.

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026